Biolegend, 100707, PE anti-mouse CD8a Antibody, 50μg

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.
50μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Mouse thymus or spleen
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).
Application References(PubMed link indicates BioLegend citation): Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP) Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete) Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP) Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block) Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC) Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC) Shih FF, et al. 2006. J. Immunol. 176:3438. (FC) Kamimura D, et al. 2006. J. Immunol. 177:306. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete) Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed Lee CH, et al. 2009. Clin. Cancer Res. PubMed Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed Kenna TJ, et al. 2008. Blood 111:2091. PubMed Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed Medyouf H, et al. 2010. Blood 115:1175. PubMed Riedl P, et al. 2009. J. Immunol. 183:370. PubMed Apte SH, et al. 2010. J. Immunol. 185:998. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed Cui L, et al. 2015. J Control Release. 206:220. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed He Y, et al. 2022. Adv Healthc Mater. 11:e2200905. PubMed Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed Wang JX, et al. 2023. JCI Insight. 8:. PubMed Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed Tang C, et al. 2023. Nat Commun. 14:1493. PubMed Hao H, et al. 2023. Nat Biomed Eng. . PubMed Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed del Rio ML, et al. 2023. Front Immunol. 14:1113858. PubMed Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed Fu S, et al. 2023. Nat Commun. 14:2248. PubMed Qin T, et al. 2023. Virol J. 20:75. PubMed Li T, et al. 2023. Nat Commun. 14:2498. PubMed Oh J, et al. 2023. Nat Commun. 14:3278. PubMed Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed Thomas R, et al. 2021. Immunology. 163:478. PubMed Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed Zveik O, et al. 2022. Glia. 70:1191. PubMed Liu H, et al. 2022. Cancer Immunol Res. 10:1028. PubMed Silva Pereira S, et al. 2022. Elife. 11: . PubMed del Rio ML, et al. 2022. Front Immunol. 13:887348. PubMed Lin G, et al. 2022. Int J Immunopathol Pharmacol. 36:3946320221117933. PubMed Zheng D, et al. 2023. Bioact Mater. 22:567. PubMed Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed He Y, et al. 2022. Front Immunol. 13:986202. PubMed Hao J, et al. 2022. Cell Rep. 41:111804. PubMed Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed An HW, et al. 2022. Cell Rep. 41:111878. PubMed Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed Huseni MA, et al. 2023. Cell Rep Med. 4:100878. PubMed Glaubitz J, et al. 2023. Gut. :. PubMed Lin J, et al. 2023. Nat Commun. 14:224. PubMed Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed Takacs GP, et al. 2023. Front Immunol. 13:993444. PubMed Pan C, et al. 2022. Cell Mol Immunol. 19:516. PubMed Kodali S, et al. 2022. J Immunol. 208:1085. PubMed Li Z, et al. 2022. Nat Commun. 13:1845. PubMed Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed Chen X, et al. 2009. Hum Immunol. 70:79. PubMed Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed Lee S, et al. 2021. JCI Insight. 6:. PubMed Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed Kagoya Y, et al. 2018. Nat Commun. 9:1915. PubMed Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed Qin Y, et al. 2021. Cell Rep. 37:109968. PubMed Sng XYX, et al. 2020. J Immunol. 204:3108. PubMed Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed Wong J, et al. 2015. Elife. 3: 07839. PubMed Ibrahim M, et al. 2016. J Evid Based Complementary Altern Med. 21: 171 - 176. PubMed He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed Zhao B, et al. 2020. Nat Commun. 11:908. PubMed van Erp EA, et al. 2019. Viruses. 0.811111111. PubMed Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed Diao L, et al. 2022. iScience. 25:105511. PubMed Ren J, et al. 2021. Theranostics. 11:304. PubMed Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed N'guessan P, et al. 2011. Antioxid Redox Signal. 15:1693. PubMed Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed Tian X, et al. 2022. Front Immunol. 13:875236. PubMed Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed Sharma S, et al. 2015. J Immunol. 194:5529. PubMed Shade K, et al. 2015. J Exp Med. 212:457. PubMed Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed Rana A, et al. 2020. Front Immunol. 11:536. PubMed Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed Jia L, et al. 2022. Front Immunol. 13:897879. PubMed Li H, et al. 2021. Nat Commun. 12:2773. PubMed Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed Perry JSA, et al. 2018. Immunity. 48:923. PubMed Li J, et al. 2019. JCI Insight. 5. PubMed Meyer LK, et al. 2019. J Clin Invest. 130:863. PubMed Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed Edwards CJ, et al. 2021. Br J Cancer. . PubMed Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed Wang B, et al. 2022. Nat Commun. 13:3821. PubMed Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed Li H, et al. 2022. Theranostics. 12:6422. PubMed Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed Qi T, et al. 2020. Cell Rep. 33:108452. PubMed Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed Lee CG, et al. 2019. JCI Insight. 4:5. PubMed Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed Yang H, et al. 2022. Nutrients. 14:. PubMed Glaros V, et al. 2021. Immunity. 54:2005. PubMed Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed Burrack K, et al. 2015. J Immunol. 194:678. PubMed Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed Becher J, et al. 2018. Dev Cell. 47:592. PubMed van Montfoort N, et al. 2018. Cell. 175:1744. PubMed Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed James OJ, et al. 2021. Nat Commun. 12:4290. PubMed Zhao X, et al. 2013. Int Immunopharmacol. 17:793. PubMed Lu X, et al. 2015. J Immunol. 194:2011. PubMed Schuldt N, et al. 2015. PLoS One. 10: 0145762. PubMed Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed Guo C, et al. 2017. Methods Mol Biol. 1709:345. PubMed Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed Loh Z, et al. 2020. PLOS Pathogens. 16(7):e1008651. PubMed Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed Cho K, et al. 2021. iScience. 24:103117. PubMed Sun C, et al. 2022. J Adv Res. 35:71. PubMed Monaghan KL, et al. 2020. J Vis Exp. . PubMed Chou T, et al. 2016. Nat Commun. 7:11904. PubMed Thomas AM, et al. 2020. Journal of Cellular Physiology. 235(6):5120-5129.. PubMed Manrique-Rincón A, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01150. PubMed Chan WF, et al. 2022. Nat Commun. 13:5582. PubMed Moutuou MM, et al. 2020. Methods Mol Biol. 2111:267. PubMed Frost JN, et al. 2021. Med (N Y). 2:164. PubMed Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed Lin J, et al. 2021. Nat Commun. 12:5321. PubMed Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed Watson MJ, et al. 2021. Nature. 591:645. PubMed Wu S, et al. 2021. Nat Cancer. 2:189. PubMed Chen C, et al. 2021. J Virol. 95:e0082921. PubMed Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed Li J, et al. 2020. FASEB J. 34:3091. PubMed Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed Rodriguez-Sosa M, et al. 2004. Infect Immun. 72:4552. PubMed Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed Yuan X, et al. 2017. Elife. 6:e29540. PubMed Zhang J, et al. 2018. Nature. 553:91. PubMed Li Z, et al. 2022. Nat Commun. 13:6321. PubMed Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed Baranwal G, et al. 2021. Physiol Rep. 9:e15094. PubMed Bristow CL, et al. 2021. Front Oncol. 11:739080. PubMed Li J, et al. 2020. Development. :. PubMed Pai M, et al. 2016. JPEN J Parenter Enteral Nutr. 40: 383 - 391. PubMed Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed Onai N, et al. 2020. Int J Mol Sci. :22. PubMed Xia Y, et al. 2018. Cell. 175:1059. PubMed Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed Tsai SJ, et al. 2021. J Biol Chem. 297:101266. PubMed Ene CI, et al. 2020. Neuro Oncol. 639:22. PubMed Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed Koide S, et al. 2022. iScience. 25:103603. PubMed Kline JM, et al. 2021. J Biol Chem. :100373. PubMed Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed Wong L, et al. 2013. J Biol Chem. 288:35170. PubMed Zhu E, et al. 2014. J Immunol. 192:5599. PubMed Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed Jia H, et al. 2018. Int J Oncol. 53:949. PubMed Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed Yoshida H, et al. 2019. Cell. 176:897. PubMed Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed Wu G, et al. 2021. Nat Cancer. 2:1170. PubMed Yang N, et al. 2022. Nat Commun. 13:2336. PubMed Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed Fedele C, et al. 2021. J Exp Med. 218: . PubMed Bonavita E, et al. 2020. Immunity. 1215:53. PubMed Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed LeBlanc P, et al. 2014. J Biol Chem. 289:7777. PubMed Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed Skirecki T, et al. 2020. JCI Insight. 5:. PubMed Sun Y, et al. 2022. iScience. 25:104846. PubMed Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed Lin J, et al. 2021. Cancer Immunol Res. 9:1413. PubMed Chavez JS, et al. 2022. Cells. 11:. PubMed Wang X, et al. 2022. Elife. 11:. PubMed Wang F, et al. 2021. Neoplasia. 23:281. PubMed Wang X, et al. 2021. Theranostics. 11:209. PubMed Angela M, et al. 2016. Nat Commun. 7:13683. PubMed Kang YA, et al. 2020. J Exp Med. 217:00:00. PubMed Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed Zeng A, et al. 2020. Oncol Rep. . PubMed Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed Chen R, et al. 2021. Front Oncol. 11:743050. PubMed Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed Zhang M, et al. 2022. iScience. 25:104490. PubMed Gawish R, et al. 2022. Elife. 11:. PubMed Lv K, et al. 2021. Cell Stem Cell. 28(7):1275-1290.e9. PubMed Yang E, et al. 2015. Acta Biochim Biophys Sin. 47: 588-596. PubMed Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed Lee YT, et al. 2018. PLoS One. 13:e0190868. PubMed Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
RRID: AB_312746 (BioLegend Cat. No. 100707) AB_312747 (BioLegend Cat. No. 100708)
Structure: Ig superfamily, CD8α chain, 34 kD
Distribution: Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells
Function: Co-receptor for TCR
Ligand/Receptor: MHC class I molecule
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Zamoyska R. 1994. Immunity 1:243. 3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.
Gene ID: 12525
UniProt: View information about CD8alpha on UniProt.org
Clone: 53-6.7
Regulatory Status: RUO
Other Names: T8, Lyt2, Ly-2
Isotype: Rat IgG2a, κ
Q: What type of PE do you use in your conjugates?
A: We use R-PE in our conjugates.